Intercept Pharmaceuticals...

NASDAQ: ICPT · Real-Time Price · USD
19.00
0.04 (0.21%)
At close: Nov 07, 2023, 10:00 PM

Intercept Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Net Income
-174.86M -91.43M
Depreciation & Amortization
592K 2.98M
Stock-Based Compensation
21.89M 33.89M
Other Working Capital
-3.45M -2.68M
Other Non-Cash Items
103.68M 39.11M
Deferred Income Tax
n/a -11.78M
Change in Working Capital
21.92M -14.42M
Operating Cash Flow
-26.78M -41.64M
Capital Expenditures
-568K -397K
Cash Acquisitions
n/a -71.12M
Purchase of Investments
-552.74M -349.46M
Sales Maturities Of Investments
451.92M 420.58M
Other Investing Acitivies
363.23M 71.12M
Investing Cash Flow
261.85M 70.73M
Debt Repayment
n/a n/a
Common Stock Repurchased
-557K -75.83M
Dividend Paid
n/a n/a
Other Financial Acitivies
-267.32M 1.12M
Financial Cash Flow
-267.32M 1.12M
Net Cash Flow
-38.55M 28.75M
Free Cash Flow
-27.35M -42.04M